Anuh Pharma (BOM:506260) 5-Year EBITDA Growth Rate : 21.70% (As of Dec. 2024)

View and export this data going back to 1993. Start your Free Trial

What is Anuh Pharma 5-Year EBITDA Growth Rate?

Anuh Pharma's EBITDA per Share for the three months ended in Dec. 2024 was ₹3.13.

During the past 12 months, Anuh Pharma's average EBITDA Per Share Growth Rate was -10.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 16.50% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 21.70% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 9.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Anuh Pharma was 29.70% per year. The lowest was -10.40% per year. And the median was 15.00% per year.

Competitive Comparison of Anuh Pharma's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Anuh Pharma's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Anuh Pharma's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Anuh Pharma's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Anuh Pharma's 5-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

Anuh Pharma 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Anuh Pharma (BOM:506260) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Anuh Pharma 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Anuh Pharma's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Anuh Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Anuh Pharma Ltd (BOM:506260) » Definitions » 5-Year EBITDA Growth Rate

Traded in Other Exchanges

ANUHPHR:India

Address

Dr. Annie Besant Road, North Wing, 3-A, Shiv Sagar Estate, Worli, Mumbai, MH, IND, 400 018

Website

https://www.anuhpharma.com

Anuh Pharma Ltd is engaged in the business of manufacturing and selling of Bulk drugs and chemicals. Geographically, it derives a majority of revenue from India. Its product categories include macrolides, anti-TB, anti-malarial, anti-bacterial, anti-hypertension, expectorant, quinolones, and others. The company generates revenue from the sale of Branded Prescription drugs, Over-the-Counter (OTC) drugs and Generic Prescription drugs.

Anuh Pharma Headlines

No Headlines